Perrigo Predicts Cough/Cold Sales Drop Due To Pseudoephedrine BTC Move
This article was originally published in The Tan Sheet
Executive Summary
Perrigo's cough/cold sales will likely be hurt in fiscal 2006 as retailers restrict pseudoephedrine products to behind-the-counter sale, according to the firm